PROSTATE MALIGNANCIES GENOMIC RISK ASSESSMENT

ASK US A QUESTION





Please prove you are human by selecting the Tree.

SERVICE DESCRIPTION

SERVICE DESCRIPTION

  1. 1
    WHAT IS PROSTATE CANCER?
    • Prostate cancer is a growth of abnormal cells in the prostate gland. The prostate is a walnut-shaped gland in the male reproductive tract that makes seminal fluid, which mixes with sperm and other fluids. This gland surrounds the urethra, near its connection to the bladder. The urethra is the tube that carries urine from the bladder, through the penis, to outside the body. Cancer develops when cells mutate and begin to multiply out of control. These cells may spread (metastasise) from the prostate to other parts of the body, especially bones and lymph nodes. In the past 20 years, the survival rate for all stages of prostate cancer has improved because of early detection and treatment.
    • A higher risk of developing prostate cancer may be related to age (especially older than 65), race (African American), and family history (father, brother).
  2. 2
    WHAT ARE THE SYMPTOMS OF PROSTATE CANCER?
    • Early prostate cancer may not cause symptoms. Some men, however, may have pain, difficulty urinating, and rarely problems with erections (erectile dysfunction).
    • Other symptoms include a weak or interrupted flow of urine, need to urinate often (especially at night), difficulty holding back urine, inability to urinate, pain or burning when urinating, blood in the urine or semen, and nagging pain in the back, hips, or pelvis.
    • It is important to realise that these symptoms may have other less serious causes, such as benign prostatic hypertrophy (BPH) or infection. Always see your doctor for a diagnosis.
  3. 3
    HOW IS PROSTATE CANCER DIAGNOSED?
    • The doctor will take a complete medical history and do a physi¬cal examination, including a digital rectal examination (DRE). A blood test called prostate-specific antigen test (PSA test) will also be done.
    • The doctor will usually recommend that a DRE and a PSA be done every year for men older than 50 until at least age 70. Men in high-risk groups, such as African Americans or those with a strong family history of prostate cancer, should ask about being tested at a younger age. The diagnosis of cancer can be confirmed only with a biopsy (a tissue sample of the prostate).
  4. 4
    WHAT ARE THE COMPLICATIONS OF PROSTATE CANCER?
    • Many prostate cancers don’t cause death, but some can spread outside the prostate gland and metastasise through the blood and lymph nodes to bones and major organs. This is known as an extracapsular spread.
  5. 5
    PROSTATE MALIGNANCIES GENOMIC RISK ASSESSMENT
    • Innovative genomic DNA testing to investigate if you are at a higher risk of developing prostate malignancy due to certain hereditary mutations in your genes.
    • This genomic test is recommended if you have a strong family history of prostate malignancies (i.e. first-degree relative who has been diagnosed with prostate malignancy).
    • You will be provided with a DNA assessment kit that contains all the necessary materials and instructions to have your DNA sample taken without any pain or stress.
    • You will be able to take your DNA sample in the comfort of your home (or you can get your treating GP or specialist to take it for you in the clinic). Afterwards, you can simply post the DNA sample back, in the provided prepaid envelope, to Genomic Medicine UK laboratory in London.
  6. 6
    OVERVIEW

    This genomic malignancy risk assessment evaluates your DNA for the following hereditary genetic mutations that may increase your risk of developing prostate malignancy:

    BRCA1

    BRCA2

    CHEK2

    HOXB13

    NBN

    TP53

  7. 7
    KNOWLEDGE IS POWER
    • If your results show that you are genetically predisposed to developing prostate malignancy, your prognosis will be significantly improved by having regular malignancy screenings at shorter intervals. Please remember that the absolute majority of malignant tumours are treatable and curable when they are caught at their early stages.
    • If your test shows that you are at a higher risk of developing prostate malignancy, this can be enormously mitigated in most of the cases by adopting a healthier lifestyle and following our malignancy prevention guidance. Please remember that genes are not a destiny book but are only a background for a multitude of different potentials.
    • It is always true that prevention is better than cure.
  8. 8
    FREE REFERRAL TO A SPECIALIST CONSULTANT

    If you your genomic testing showed that you require referral to a specialist consultant, we will provide you, at no cost to you, with a referral letter to a specialist consultant from our wide network of independent doctors all around the United Kingdom. Our referral letter will give the specialist consultant all the needed details to take care of your clinical case, according to the results of the genomic tests you have had at Genomic Medicine UK.

  9. 9
    QUALITY ASSURANCE
    • This advanced genomic test is carried out by cutting-edge next-generation DNA sequencing technology at our ISO9000 certified and accredited laboratory.
    • All test results are interpreted and reported in London by our highly qualified licenced consultant medical doctors.
  10. 10
    FREQUENTLY ASKED QUESTIONS
  11. 11
    FURTHER INFORMATION
  12. 12
    SAMPLE REPORTS
  13. 13
    BY POST OR BY APPOINTMENT

    If you prefer to visit Genomic Medicine UK instead of having your genomic test by post, as explained above, you are most welcome to book a suitable appointment for you to visit our premises in central London where our fully trained and friendly staff will be more than happy to take your DNA sample in one of our outpatients’ clinics in Harley Street.

£499.00

£499.000

Innovative genomic DNA testing to investigate if you are at a higher risk of developing prostate malignancy due to certain hereditary mutations …

X